Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain

A. Straskova, L. Cerveny, P. Spidlova, V. Dankova, D. Belcic, M. Santic, J. Stulik,

. 2012 ; 14 (2) : 177-187.

Jazyk angličtina Země Francie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13031952

Grantová podpora
NS9747 MZ0 CEP - Centrální evidence projektů

Francisella tularensis, the causative agent of tularemia, is a highly infectious intracellular pathogen with no licensed vaccine available today. The recent search for genome sequences involved in F. tularensis virulence mechanisms led to the identification of the 30-kb region defined as a Francisella pathogenicity island (FPI). In our previous iTRAQ study we described the concerted upregulation of some FPI proteins in different F. tularensis strains cultivated under stress conditions. Among them we identified the IglH protein whose role in Francisella virulence has not been characterized yet. In this work we deleted the iglH gene in a European clinical isolate of F. tularensis subsp. holarctica FSC200. We showed that the iglH gene is necessary for intracellular growth and escape of F. tularensis from phagosomes. We also showed that the iglH mutant is avirulent in a mouse model of infection and persists in the organs for about three weeks after infection. Importantly, mice vaccinated by infection with the iglH mutant were protected against subcutaneous challenge with the fully virulent parental FSC200 strain. This is the first report of a defined subsp. holarctica FPI deletion strain that provides protective immunity against subsequent subcutaneous challenge with a virulent isolate of F. tularensis subsp. holarctica.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13031952
003      
CZ-PrNML
005      
20140916081417.0
007      
ta
008      
131002s2012 fr f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.micinf.2011.08.017 $2 doi
035    __
$a (PubMed)21930232
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a fr
100    1_
$a Straskova, Adela $u Center of Advanced Studies, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 50001 Hradec Kralove, Czech Republic. straskova@pmfhk.cz
245    10
$a Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain / $c A. Straskova, L. Cerveny, P. Spidlova, V. Dankova, D. Belcic, M. Santic, J. Stulik,
520    9_
$a Francisella tularensis, the causative agent of tularemia, is a highly infectious intracellular pathogen with no licensed vaccine available today. The recent search for genome sequences involved in F. tularensis virulence mechanisms led to the identification of the 30-kb region defined as a Francisella pathogenicity island (FPI). In our previous iTRAQ study we described the concerted upregulation of some FPI proteins in different F. tularensis strains cultivated under stress conditions. Among them we identified the IglH protein whose role in Francisella virulence has not been characterized yet. In this work we deleted the iglH gene in a European clinical isolate of F. tularensis subsp. holarctica FSC200. We showed that the iglH gene is necessary for intracellular growth and escape of F. tularensis from phagosomes. We also showed that the iglH mutant is avirulent in a mouse model of infection and persists in the organs for about three weeks after infection. Importantly, mice vaccinated by infection with the iglH mutant were protected against subcutaneous challenge with the fully virulent parental FSC200 strain. This is the first report of a defined subsp. holarctica FPI deletion strain that provides protective immunity against subsequent subcutaneous challenge with a virulent isolate of F. tularensis subsp. holarctica.
650    _2
$a zvířata $7 D000818
650    _2
$a bakteriální proteiny $x genetika $x imunologie $7 D001426
650    _2
$a bakteriální vakcíny $x genetika $x imunologie $7 D001428
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a Francisella tularensis $x genetika $x imunologie $x patogenita $7 D005604
650    _2
$a testy genetické komplementace $7 D005816
650    _2
$a makrofágy $x mikrobiologie $7 D008264
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední BALB C $7 D008807
650    _2
$a fagozomy $x mikrobiologie $7 D010588
650    _2
$a sekvenční delece $7 D017384
650    _2
$a tularemie $x imunologie $x mikrobiologie $x prevence a kontrola $7 D014406
650    _2
$a atenuované vakcíny $x genetika $x imunologie $7 D014613
650    _2
$a virulence $7 D014774
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Cerveny, Lukas $u -
700    1_
$a Spidlova, Petra $u -
700    1_
$a Dankova, Vera $u -
700    1_
$a Belcic, Davor $u -
700    1_
$a Santic, Marina $u -
700    1_
$a Stulik, Jiri $u -
773    0_
$w MED00006000 $t Microbes and infection / Institut Pasteur $x 1769-714X $g Roč. 14, č. 2 (2012), s. 177-187
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21930232 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20131002 $b ABA008
991    __
$a 20140916081826 $b ABA008
999    __
$a ok $b bmc $g 996039 $s 830397
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 14 $c 2 $d 177-187 $i 1769-714X $m Microbes and infection $n Microbes Infect $x MED00006000
GRA    __
$a NS9747 $p MZ0
LZP    __
$a Pubmed-20131002

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...